Drug Approval | November 23, 2022
USFDA grants priority review of BLA for dengue vaccine TAK-003
If approved, TAK-003 has the potential to become an important dengue prevention option for healthcare providers
If approved, TAK-003 has the potential to become an important dengue prevention option for healthcare providers
The company is making its entry into the Hyderabad market through its unique asset-light business model
The participants discussed the latest developments under ABDM that shall enable true interoperability in the health sector and how effective adoption of ABDM can pave the way towards Universal Health Coverage
NABH shall encourage and provide assistance in onboarding their accredited/certified facilities on ABDM’s Health Facility Registry
The training center will focus on providing radiation oncologists, radiotherapy technologists, and medical physicists with the necessary skills
Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite
99% of Pristyn Doctors are using EMR facility on its doctor app
Therapy recently approved in Canada under the brand name KORSUVA
New deal strengthens Congenica’s presence in India
Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
Subscribe To Our Newsletter & Stay Updated
